240 related articles for article (PubMed ID: 7949202)
21. Aromatase expression in endometriosis.
Noble LS; Simpson ER; Johns A; Bulun SE
J Clin Endocrinol Metab; 1996 Jan; 81(1):174-9. PubMed ID: 8550748
[TBL] [Abstract][Full Text] [Related]
22. Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR.
Agarwal VR; Bulun SE; Simpson ER
Mol Cell Probes; 1995 Dec; 9(6):453-64. PubMed ID: 8808317
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
24. Sources of estrogen and their importance.
Simpson ER
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):225-30. PubMed ID: 14623515
[TBL] [Abstract][Full Text] [Related]
25. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.
Zhou D; Zhou C; Chen S
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):273-80. PubMed ID: 9365201
[TBL] [Abstract][Full Text] [Related]
26. Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer.
Díaz-Cruz ES; Brueggemeier RW
Anticancer Agents Med Chem; 2006 May; 6(3):221-32. PubMed ID: 16712450
[TBL] [Abstract][Full Text] [Related]
27. Ligands for the peroxisomal proliferator-activated receptor gamma and the retinoid X receptor inhibit aromatase cytochrome P450 (CYP19) expression mediated by promoter II in human breast adipose.
Rubin GL; Duong JH; Clyne CD; Speed CJ; Murata Y; Gong C; Simpson ER
Endocrinology; 2002 Aug; 143(8):2863-71. PubMed ID: 12130549
[TBL] [Abstract][Full Text] [Related]
28. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast.
Bulun SE; Sharda G; Rink J; Sharma S; Simpson ER
J Clin Endocrinol Metab; 1996 Mar; 81(3):1273-7. PubMed ID: 8772611
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture.
Zhao Y; Agarwal VR; Mendelson CR; Simpson ER
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):203-10. PubMed ID: 9365191
[TBL] [Abstract][Full Text] [Related]
30. Regulated CYP19 aromatase transcription in breast stromal fibroblasts.
Pauley RJ; Santner SJ; Tait LR; Bright RK; Santen RJ
J Clin Endocrinol Metab; 2000 Feb; 85(2):837-46. PubMed ID: 10690899
[TBL] [Abstract][Full Text] [Related]
31. Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age.
Bulun SE; Simpson ER
J Clin Endocrinol Metab; 1994 Feb; 78(2):428-32. PubMed ID: 8106632
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
33. Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.
Brueggemeier RW; Díaz-Cruz ES; Li PK; Sugimoto Y; Lin YC; Shapiro CL
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):129-36. PubMed ID: 15964185
[TBL] [Abstract][Full Text] [Related]
34. Endocrine disorders associated with inappropriately high aromatase expression.
Bulun SE; Noble LS; Takayama K; Michael MD; Agarwal V; Fisher C; Zhao Y; Hinshelwood MM; Ito Y; Simpson ER
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):133-9. PubMed ID: 9365182
[TBL] [Abstract][Full Text] [Related]
35. Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction.
Zhou C; Zhou D; Esteban J; Murai J; Siiteri PK; Wilczynski S; Chen S
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):163-71. PubMed ID: 9010331
[TBL] [Abstract][Full Text] [Related]
36. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4.
Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER
Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461
[TBL] [Abstract][Full Text] [Related]
38. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues.
Means GD; Kilgore MW; Mahendroo MS; Mendelson CR; Simpson ER
Mol Endocrinol; 1991 Dec; 5(12):2005-13. PubMed ID: 1724289
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the regulatory regions of the human aromatase (P450arom) gene involved in placenta-specific expression.
Kamat A; Alcorn JL; Kunczt C; Mendelson CR
Mol Endocrinol; 1998 Nov; 12(11):1764-77. PubMed ID: 9817601
[TBL] [Abstract][Full Text] [Related]
40. Aromatase and cyclooxygenases: enzymes in breast cancer.
Brueggemeier RW; Richards JA; Petrel TA
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):501-7. PubMed ID: 14623550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
